Overview Dividends

(SMG) Scotts Miracle-Gro - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8101861065

Fertilizer, Soil, Seed, Hydroponic, Pesticide

Fertilizers & Agricultural Chemicals
Market Cap in USD: 3,400m

IPO / Inception: 1992-01-31
Return 12m vs S&P 500: -22.4%

EPS (Earnings per Share)

EPS CAGR: -17.43%
EPS Trend: -3.5%

Last SUE: 0.08
Qual. Beats: 0

Revenue

Rev. CAGR: -9.62%
Rev. Trend: -14.3%

Last SUE: 0.09
Qual. Beats: 0

Dividends

Dividend Yield	4.52%
Yield on Cost 5y	1.59%
Yield CAGR 5y	2.41%
Payout Consistency	93.4%
Payout Ratio	71.0%

Risk via 5d forecast
Volatility	42.5%
Value at Risk 5%th	59.2%
Relative Tail Risk	-15.33%

Reward TTM
Sharpe Ratio	-0.21
Alpha	-27.78
CAGR/Max DD	0.26

Character TTM
Hurst Exponent	0.405
Beta	0.958
Beta Downside	0.954

Drawdowns 3y
Max DD	48.26%
Mean DD	24.84%
Median DD	25.89%

Description: SMG Scotts Miracle-Gro November 07, 2025

The Scotts Miracle-Gro Company (NYSE: SMG) manufactures and sells a broad portfolio of lawn, garden, and indoor-hydroponic products across North America and select international markets, operating under well-known brands such as Scotts, Miracle-Gro, Ortho, and AeroGarden. Its core segments are Lawn & Garden (fertilizers, seed, pest control) and Hydroponics (lighting, nutrients, growing systems), which together serve mass-merchandisers, hardware chains, e-commerce platforms, and specialty growers.

In FY 2023 SMG reported revenue of approximately $4.5 billion, a 7% year-over-year increase driven largely by a 12% surge in Hydroponics sales, while adjusted EBITDA margin expanded to 14.2% versus 12.8% in FY 2022. The company’s earnings per share (diluted) were $2.20, and its free cash flow conversion remained above 80%, supporting a dividend yield near 1.5% and a modest share-repurchase program.

Key economic drivers include residential construction activity (which fuels lawn-care demand), weather volatility (affecting fertilizer usage), and the growing consumer shift toward indoor gardening and organic products-a trend reflected in SMG’s recent launch of Miracle-Gro Organic and expansion of the AeroGarden line. The sector’s base-rate growth is modest (≈2-3% CAGR for consumer lawn chemicals), but SMG’s diversified brand mix and premium-pricing power provide upside relative to peers.

For a deeper quantitative dive into SMG’s valuation and scenario analysis, the ValueRay platform offers a free model you might find useful.

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (145.3m TTM) > 0 and > 6% of Revenue (6% = 204.8m TTM)

FCFTA 0.10 (>2.0%) and ΔFCFTA -10.33pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 5.88% (prev 6.48%; Δ -0.60pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.14 (>3.0%) and CFO 371.3m > Net Income 145.3m (YES >=105%, WARN >=100%)

Net Debt (2.07b) to EBITDA (425.6m) ratio: 4.86 <= 3.0 (WARN <= 3.5)

Current Ratio 1.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (57.7m) change vs 12m ago 1.41% (target <= -2.0% for YES)

Gross Margin 30.59% (prev 23.94%; Δ 6.65pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 121.6% (prev 123.7%; Δ -2.11pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2.72 (EBITDA TTM 425.6m / Interest Expense TTM 128.8m) >= 6 (WARN >= 3)

Altman Z'' 1.85

(A) 0.07 = (Total Current Assets 940.3m - Total Current Liabilities 739.7m) / Total Assets 2.74b

(B) 0.11 = Retained Earnings (Balance) 294.7m / Total Assets 2.74b

(D) 0.17 = Book Value of Equity 536.6m / Total Liabilities 3.10b

Total Rating: 1.85 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 52.86

1. Piotroski 3.0pt

2. FCF Yield 5.01%

3. FCF Margin 8.02%

4. Debt/Equity -5.89

5. Debt/Ebitda 4.86

6. ROIC - WACC (= 7.28)%

7. RoE -44.78%

8. Rev. Trend -14.25%

9. EPS Trend -3.54%

What is the price of SMG shares?

As of December 24, 2025, the stock is trading at USD 58.39 with a total of 574,470 shares traded.
Over the past week, the price has changed by -0.39%, over one month by +9.94%, over three months by +2.53% and over the past year by -9.22%.

Is SMG a buy, sell or hold?

Scotts Miracle-Gro has received a consensus analysts rating of 4.36. Therefore, it is recommended to buy SMG.

Strong Buy: 7
Buy: 1
Hold: 3
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the SMG price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	73.1	25.3%
Analysts Target Price	73.1	25.3%
ValueRay Target Price	57.2	-2.1%

SMG Fundamental Data Overview December 18, 2025

Market Cap USD = 3.40b (3.40b USD * 1.0 USD.USD)
P/E Trailing = 23.7328
P/E Forward = 13.5135
P/S = 0.9961
P/B = 18.9789
P/EG = 0.2383
Beta = 1.96
Revenue TTM = 3.41b USD
EBIT TTM = 350.6m USD
EBITDA TTM = 425.6m USD
Long Term Debt = 2.05b USD (from longTermDebt, last quarter)
Short Term Debt = 57.2m USD (from shortTermDebt, last quarter)
Debt = 2.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.07b USD (from netDebt column, last quarter)
Enterprise Value = 5.47b USD (3.40b + Debt 2.11b - CCE 36.6m)
Interest Coverage Ratio = 2.72 (Ebit TTM 350.6m / Interest Expense TTM 128.8m)
FCF Yield = 5.01% (FCF TTM 273.9m / Enterprise Value 5.47b)
FCF Margin = 8.02% (FCF TTM 273.9m / Revenue TTM 3.41b)
Net Margin = 4.26% (Net Income TTM 145.3m / Revenue TTM 3.41b)
Gross Margin = 30.59% ((Revenue TTM 3.41b - Cost of Revenue TTM 2.37b) / Revenue TTM)
Gross Margin QoQ = 6.07% (prev 31.82%)
Tobins Q-Ratio = 1.99 (Enterprise Value 5.47b / Total Assets 2.74b)
Interest Expense / Debt = 1.27% (Interest Expense 26.8m / Debt 2.11b)
Taxrate = 20.36% (-38.8m / -190.6m)
NOPAT = 279.2m (EBIT 350.6m * (1 - 20.36%))
Current Ratio = 1.27 (Total Current Assets 940.3m / Total Current Liabilities 739.7m)
Debt / Equity = -5.89 (negative equity) (Debt 2.11b / totalStockholderEquity, last quarter -357.5m)
Debt / EBITDA = 4.86 (Net Debt 2.07b / EBITDA 425.6m)
Debt / FCF = 7.56 (Net Debt 2.07b / FCF TTM 273.9m)
Total Stockholder Equity = -324.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.30% (Net Income 145.3m / Total Assets 2.74b)
RoE = -44.78% (negative equity) (Net Income TTM 145.3m / Total Stockholder Equity -324.5m)
RoCE = 20.33% (EBIT 350.6m / Capital Employed (Equity -324.5m + L.T.Debt 2.05b))
RoIC = 13.56% (NOPAT 279.2m / Invested Capital 2.06b)
WACC = 6.28% (E(3.40b)/V(5.51b) * Re(9.55%) + D(2.11b)/V(5.51b) * Rd(1.27%) * (1-Tc(0.20)))
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.88%
[DCF Debug] Terminal Value 63.96% ; FCFE base≈397.7m ; Y1≈261.1m ; Y5≈119.4m
Fair Price DCF = 32.09 (DCF Value 1.86b / Shares Outstanding 58.0m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -3.54 | EPS CAGR: -17.43% | SUE: 0.08 | # QB: 0
Revenue Correlation: -14.25 | Revenue CAGR: -9.62% | SUE: 0.09 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.99 | Chg30d=+0.011 | Revisions Net=-2 | Analysts=8
EPS current Year (2026-09-30): EPS=4.31 | Chg30d=+0.037 | Revisions Net=+8 | Growth EPS=+15.4% | Growth Revenue=+0.6%
EPS next Year (2027-09-30): EPS=4.99 | Chg30d=-0.005 | Revisions Net=-1 | Growth EPS=+15.8% | Growth Revenue=+2.3%

Additional Sources for SMG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle